<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01795638</url>
  </required_header>
  <id_info>
    <org_study_id>09-07-28-07</org_study_id>
    <nct_id>NCT01795638</nct_id>
  </id_info>
  <brief_title>Sodium Supplementation and Growth in Very Low Birth Weight Infants</brief_title>
  <acronym>SSALT</acronym>
  <official_title>Impact of Early Postnatal Sodium Supplementation on Weight Gain in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adequate growth during the neonatal period is critical for optimal long term outcomes.&#xD;
      Despite maximal calorie intake, sixty percent of very low birth weight infants still fail to&#xD;
      thrive suggesting that factors other than total calorie intake are important in ensuring&#xD;
      consistent weight gain. Several reports have indicated a positive sodium balance is critical&#xD;
      in ensuring good weight gain in very low birth weight infants, however these infants are&#xD;
      susceptible to low serum sodium concentrations. Urine sodium values are sometimes used to&#xD;
      diagnosis of hyponatremia or negative sodium balance after the first two weeks of life, but&#xD;
      there is no evidence for this practice in preterm neonates. Our central hypothesis is that&#xD;
      early supplementation with sodium will ensure positive sodium balance in very low birth&#xD;
      weight infants and will result in optimal weight gain and enhanced long term outcomes.&#xD;
      Secondarily we hypothesize that low sodium concentrations in the urine will not correlate&#xD;
      with low serum sodium values.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, blinded, placebo-controlled trial in infants born at less than 32 weeks&#xD;
      gestation, who are admitted to the Newborn Intensive Care Unit at University of Cincinnati&#xD;
      Medical Center, Cincinnati, Ohio. Infants are randomized to receive either 4 meq/kg/day&#xD;
      supplemental sodium or an equal amount of sterile water on days of life 7-35. Institutional&#xD;
      data from 2008 revealed that a sample size of 56 infants completing the study will detect a&#xD;
      15% difference in the primary outcome of weight gain with 80% power and an alpha error of&#xD;
      0.05. Allowing that 33% drop-out rate (infants may be transferred to another hospital,&#xD;
      expire, or be discharged prior to day of life 35), we choose to randomize 75 infants. Calorie&#xD;
      intake, serum sodium, weight gain, urine sodium were monitored weekly till 35 days of life or&#xD;
      discharge. Infants were assessed for common morbidities associated with prematurity including&#xD;
      bronchopulmonary dysplasia, systemic hypertension, late-onset sepsis, necrotizing&#xD;
      enterocolitis and retinopathy of prematurity.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The unit's standard nutrition practices change which impacted our methodology.&#xD;
  </why_stopped>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight Gain at Six Weeks of Age</measure>
    <time_frame>Six weeks of age</time_frame>
    <description>Average weight gain in g/kg/day and also as a % birthweight over the first six weeks of the study will be compared between the two study arms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body Length at Six Weeks of Age</measure>
    <time_frame>six weeks of age</time_frame>
    <description>The percentage of infants maintaining birth percentile at six weeks between the two study arms will be analyzed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head Circumference</measure>
    <time_frame>six weeks of age</time_frame>
    <description>The percentage of infants maintaining birth percentile for head circumference will be compared between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Systolic Blood Pressure</measure>
    <time_frame>36 weeks post-conceptual age</time_frame>
    <description>Systolic blood pressures at 36 weeks post-conceptual age will be compared between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Diuretic Therapy</measure>
    <time_frame>patients will be followed during birth hospital stay; an expected average of 3 months of age</time_frame>
    <description>The incidence of chronic diuretic therapy will be compared between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late-onset Sepsis</measure>
    <time_frame>patients will be followed during birth hospitalization; an expected average of 3 months of age</time_frame>
    <description>The incidence of late-onset sepsis, defined as positive blood culture for credible pathogen and/or 5 days of continuous antimicrobial therapy after the first week of life will be compared between the two groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necrotizing Enterocolitis</measure>
    <time_frame>patients will be followed during birth hospitalization; an expected average of 3 months of age</time_frame>
    <description>The incidence of Bell stage II or greater necrotizing enterocolitis after the second week of life will be compared between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Lung Disease</measure>
    <time_frame>36 weeks post-mentrual age</time_frame>
    <description>The incidence of chronic lung disease, defined as respiratory support at 36 weeks postmenstrual age will be compared between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>patients will be followed during birth hospitalization; an expected 3 months of age</time_frame>
    <description>The incidence of death during birth hospitalization will be compared between the two study arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patent Ductus Arteriosus</measure>
    <time_frame>After the second week of life</time_frame>
    <description>prolonged Patent Ductus Arteriosus after the second week of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Extreme Immaturity</condition>
  <arm_group>
    <arm_group_label>Sodium chloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sterile water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium chloride</intervention_name>
    <arm_group_label>Sodium chloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
    <arm_group_label>sterile water</arm_group_label>
    <other_name>Sterile Water</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  infants born at less than 32 weeks postmenstrual age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  infants with major malformations deemed incompatible with life disease states&#xD;
             characterized by edema renal failure, defined as an increase in serum creatinine by&#xD;
             0.5 mg/dl/day or urine output less than 0.5 ml/kg/hour&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henry T Akinbi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cincinnati Childrens Hospital Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cincinnati Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <study_first_submitted>February 13, 2013</study_first_submitted>
  <study_first_submitted_qc>February 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2013</study_first_posted>
  <results_first_submitted>March 22, 2016</results_first_submitted>
  <results_first_submitted_qc>August 21, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 7, 2020</results_first_posted>
  <last_update_submitted>August 21, 2020</last_update_submitted>
  <last_update_submitted_qc>August 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anthropometrics</keyword>
  <keyword>weight</keyword>
  <keyword>nutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>transferred to quaternary hospital</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>discharged from hospital</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Infants met inclusion criteria and [parents consented for their infants to participate</population>
      <group_list>
        <group group_id="B1">
          <title>Sodium Chloride</title>
          <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
        </group>
        <group group_id="B2">
          <title>Sterile Water</title>
          <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.4" lower_limit="24" upper_limit="31.9"/>
                    <measurement group_id="B2" value="29.3" lower_limit="23.9" upper_limit="31.7"/>
                    <measurement group_id="B3" value="28.5" lower_limit="24" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight at birth in grams</title>
          <units>grams</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1080" lower_limit="551" upper_limit="1669"/>
                    <measurement group_id="B2" value="1021" lower_limit="551" upper_limit="1785"/>
                    <measurement group_id="B3" value="1051" lower_limit="551" upper_limit="1785"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body length at birth in centimeters</title>
          <units>centimeters</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.8" lower_limit="27" upper_limit="41"/>
                    <measurement group_id="B2" value="34.9" lower_limit="28.5" upper_limit="39"/>
                    <measurement group_id="B3" value="35.4" lower_limit="27" upper_limit="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Head circumference at birth in centimeters</title>
          <units>centimeters</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.1" lower_limit="21.5" upper_limit="29"/>
                    <measurement group_id="B2" value="24.6" lower_limit="21.5" upper_limit="28"/>
                    <measurement group_id="B3" value="24.9" lower_limit="21.5" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Modified CRIB score</title>
          <description>Clinical Risk Index for Babies scoring system (CRIB II) score is a tool to predict initial risk of mortality amongst low birth weight babies.&#xD;
Scale ranges: 0-15 with 0 being the least severe and 15 being the most severe</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1" lower_limit="0" upper_limit="15"/>
                    <measurement group_id="B2" value="2" lower_limit="0" upper_limit="15"/>
                    <measurement group_id="B3" value="1" lower_limit="0" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Maternal Milk as Primary Diet</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Weight Gain at Six Weeks of Age</title>
        <description>Average weight gain in g/kg/day and also as a % birthweight over the first six weeks of the study will be compared between the two study arms</description>
        <time_frame>Six weeks of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Weight Gain at Six Weeks of Age</title>
          <description>Average weight gain in g/kg/day and also as a % birthweight over the first six weeks of the study will be compared between the two study arms</description>
          <units>g/kg/day</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.9" lower_limit="24.7" upper_limit="29.2"/>
                    <measurement group_id="O2" value="22.4" lower_limit="20.2" upper_limit="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Length at Six Weeks of Age</title>
        <description>The percentage of infants maintaining birth percentile at six weeks between the two study arms will be analyzed</description>
        <time_frame>six weeks of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Body Length at Six Weeks of Age</title>
          <description>The percentage of infants maintaining birth percentile at six weeks between the two study arms will be analyzed</description>
          <units>percentage</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Head Circumference</title>
        <description>The percentage of infants maintaining birth percentile for head circumference will be compared between the two groups.</description>
        <time_frame>six weeks of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Head Circumference</title>
          <description>The percentage of infants maintaining birth percentile for head circumference will be compared between the two groups.</description>
          <units>percent</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Systolic Blood Pressure</title>
        <description>Systolic blood pressures at 36 weeks post-conceptual age will be compared between the two groups</description>
        <time_frame>36 weeks post-conceptual age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Systolic Blood Pressure</title>
          <description>Systolic blood pressures at 36 weeks post-conceptual age will be compared between the two groups</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.4" lower_limit="74" upper_limit="96"/>
                    <measurement group_id="O2" value="81.8" lower_limit="70" upper_limit="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chronic Diuretic Therapy</title>
        <description>The incidence of chronic diuretic therapy will be compared between the two groups</description>
        <time_frame>patients will be followed during birth hospital stay; an expected average of 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Chronic Diuretic Therapy</title>
          <description>The incidence of chronic diuretic therapy will be compared between the two groups</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Late-onset Sepsis</title>
        <description>The incidence of late-onset sepsis, defined as positive blood culture for credible pathogen and/or 5 days of continuous antimicrobial therapy after the first week of life will be compared between the two groups.</description>
        <time_frame>patients will be followed during birth hospitalization; an expected average of 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Late-onset Sepsis</title>
          <description>The incidence of late-onset sepsis, defined as positive blood culture for credible pathogen and/or 5 days of continuous antimicrobial therapy after the first week of life will be compared between the two groups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Necrotizing Enterocolitis</title>
        <description>The incidence of Bell stage II or greater necrotizing enterocolitis after the second week of life will be compared between the two groups</description>
        <time_frame>patients will be followed during birth hospitalization; an expected average of 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Necrotizing Enterocolitis</title>
          <description>The incidence of Bell stage II or greater necrotizing enterocolitis after the second week of life will be compared between the two groups</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chronic Lung Disease</title>
        <description>The incidence of chronic lung disease, defined as respiratory support at 36 weeks postmenstrual age will be compared between the two groups</description>
        <time_frame>36 weeks post-mentrual age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Chronic Lung Disease</title>
          <description>The incidence of chronic lung disease, defined as respiratory support at 36 weeks postmenstrual age will be compared between the two groups</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality</title>
        <description>The incidence of death during birth hospitalization will be compared between the two study arms</description>
        <time_frame>patients will be followed during birth hospitalization; an expected 3 months of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Mortality</title>
          <description>The incidence of death during birth hospitalization will be compared between the two study arms</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patent Ductus Arteriosus</title>
        <description>prolonged Patent Ductus Arteriosus after the second week of life</description>
        <time_frame>After the second week of life</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
          </group>
        </group_list>
        <measure>
          <title>Patent Ductus Arteriosus</title>
          <description>prolonged Patent Ductus Arteriosus after the second week of life</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>Sodium chloride 1 meq/kg (0.4 ml/kg of 2.5meq/ml formulation for injection)q6hrs on days of life 7-35. Intervention was given enterally if feedings were at least 100 ml/kg/day; otherwise medication was diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Sodium chloride</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Sterile water, 0.4 ml/kg q6hrs on days of life 7-35. Placebo is given enterally when infant is tolerating at least 100 ml/kg/day; otherwise the product is diluted in equal amounts of dextrose 5% water and administered intravenously.&#xD;
Placebo: sterile water, 0.4 ml/kg every 6 hours on days of life 7-35.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>hypernatremia</sub_title>
                <description>three infants receiving intervention contemporaneously with maintainence intravenous fluids developed hypernatremia (range 150-151mmol/L) and were withdrawn from the study, per defined protocol.</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study was terminated after 95% of sample size was recruited. Small number of subjects are analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Barbara Isemann</name_or_title>
      <organization>University of Cincinnati Medical Center</organization>
      <phone>513-584-5060</phone>
      <email>barbara.isemann@uchealth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

